z.cardoso
TL2 Moderator · Dhaka
Contributes reviews on supplier material. Based in Dhaka.
Joined 28 April 2025 · last posted 2d
68 posts, newest first. Showing up to 150.
-
What a reversed-phase purity number actually is Replied, post #96 · Analytics › HPLC & UHPLC · 26 Jul 2026 · 20 likes On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #73 · Clinical › Prescriber conversations · 24 Jul 2026 · 16 likes post #72 is right about the mechanism and I think understates the practical bit. Questions about dose: asking "how will we determine whether this dose is working for…
-
Restarting after a long gap: what the labelling implies Replied, post #38 · Practice › Dosing & titration · 22 Jul 2026 · 0 likes This follows post #35 rather than contradicting it. Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #117 · Start Here › How to Ask · 11 Jul 2026 · 24 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #69 · Analytics › Home & field testing · 7 Jul 2026 · 6 likes post #68 answers the question as asked. The question underneath it is different. Immunoassay limitations: tests that use antibodies have cross-reactivity limitations.…
-
Here for the analytics and not much else Replied, post #2 · Lounge › Introductions · 6 Jul 2026 · 23 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #51 · Analytics › Impurities & related substances · 6 Jul 2026 · 4 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Fixed versus detachable needles: the trade-offs — does this still hold? Replied, post #8 · marked as the solution · Devices › Syringes & needles · 20 Jun 2026 · 7 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Racemisation and why it is invisible to a mass measurement Replied, post #124 · Analytics › Impurities & related substances · 15 Jun 2026 · 20 likes Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
-
Transporting a vial for a weekend away — a second dataset Replied, post #78 · Practice › Storage & stability · 10 Jun 2026 · 0 likes Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on…
-
Research-use-only status: what it means legally and practically Replied, post #54 · Compounds › Other compounds · 7 Jun 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
What changed in 2026, by region — does this still hold? Replied, post #10 · Access › International · 22 May 2026 · 26 likes post #9 answers the question as asked. The question underneath it is different. Language barriers: if you need to communicate with a supplier, clinician, or regulator…
-
A site rotation scheme that is easy enough to actually follow Replied, post #66 · Practice › Administration · 18 May 2026 · 2 likes On post #62 — agreed on the reasoning, with one qualification. Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles.…
-
Official shortage notices and what they authorise Replied, post #20 · Access › Shortages · 25 Apr 2026 · 18 likes Picking up post #17: that is the part I would want checked first. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when…
-
The "under review" status pill and when a moderator applies it Replied, post #91 · Evidence › Preprints · 23 Apr 2026 · 29 likes Coming back to post #89, because the follow-up matters more than the original answer. How to cite a preprint: author last name, first initial, et al. Title. Server name…
-
Sample handling between despatch and injection Replied, post #61 · Analytics › Method validation · 23 Apr 2026 · 16 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #150 · Access › Pricing · 18 Apr 2026 · 6 likes On post #146 — agreed on the reasoning, with one qualification. Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That…
-
The "under review" status pill and when a moderator applies it Replied, post #74 · Evidence › Preprints · 15 Apr 2026 · 0 likes This follows post #71 rather than contradicting it. Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite…
-
Sample size intuition for a personal experiment — does this still hold? Replied, post #9 · Research Methods › Statistics · 20 Mar 2026 · 2 likes Regression to the mean: if you select people with extreme values (very high or very low), their next measurement is often less extreme just by chance. This can look…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #75 · Start Here › How to Ask · 18 Mar 2026 · 26 likes Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method. Everything else follows from method. A chromatogram without…
-
Reading an interaction checker output critically Replied, post #145 · Practice › Interactions · 13 Mar 2026 · 2 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #20 · Compounds › Cagrilintide & amylin analogues · 3 Mar 2026 · 18 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #31 · Access › International · 24 Feb 2026 · 22 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #40 · Clinical › Special populations · 12 Feb 2026 · 27 likes post #39 is right about the mechanism and I think understates the practical bit. Medullary thyroid carcinoma history: an absolute contraindication because of the…
-
Whether protein timing matters at a large deficit Replied, post #22 · Nutrition & Training › Protein & intake · 3 Feb 2026 · 3 likes I read post #20 twice before replying, because I had assumed the opposite. Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during…
-
Heterogeneity as information rather than as a nuisance Replied, post #88 · Evidence › Meta-analyses · 3 Feb 2026 · 16 likes I read post #86 twice before replying, because I had assumed the opposite. Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating…
-
Sulfonylureas: the interaction most worth taking seriously Replied, post #2 · Practice › Interactions · 28 Jan 2026 · 3 likes the opening post is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #48 · Practice › Side effects · 17 Jan 2026 · 1 like post #47 is right about the mechanism and I think understates the practical bit. Hair shedding: telogen effluvium associated with rapid weight loss is reported. The…
-
Second pass at: Fasting versus non-fasting and which tests care Replied, post #6 · Clinical › Bloodwork · 5 Jan 2026 · 19 likes Coming back to post #4, because the follow-up matters more than the original answer. Fasting state: some lab tests require fasting; others do not. Lipids on a fasting…
-
Documentation that appears only after payment Replied, post #121 · Sourcing › Red flags · 29 Dec 2025 · 9 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #54 · Compounds › Oral incretins · 29 Nov 2025 · 0 likes Coming back to post #52, because the follow-up matters more than the original answer. PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy…
-
Specification in the result column: why that is a meaningful error Replied, post #78 · Analytics › COA interpretation · 24 Nov 2025 · 0 likes This follows post #75 rather than contradicting it. What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated…
-
DXA precision and the least significant change for lean mass Started this topic · Outcomes › Body composition · 14 Nov 2025 · 0 likes Posting this under the heading it deserves: DXA precision and the least significant change for lean mass Everything below is what sits behind that. Maintenance rather…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #65 · Safety › Adverse events · 28 Oct 2025 · 3 likes Acute kidney injury: rare but reported. Symptoms (decreased urine output, creatinine elevation) warrant urgent evaluation. Severe dehydration during weight loss is a…
-
High-resolution MS on aggregates and what it can see Replied, post #89 · Analytics › Mass spectrometry · 10 Oct 2025 · 13 likes Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #145 · Data & Tools › Datasets · 11 Sep 2025 · 28 likes Temporal bias: older data in a dataset might reflect conditions (supplier, formulation, context) that have changed. Newer data is more current.
-
What pooling buys you and what it destroys Replied, post #17 · Evidence › Meta-analyses · 7 Sep 2025 · 2 likes post #16 answers the question as asked. The question underneath it is different. Why forest plots are more informative than pooled numbers: they show the variation…
-
When a preprint is the best available evidence and we say so Replied, post #143 · Evidence › Preprints · 5 Sep 2025 · 5 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Started this topic · Compounds › Tirzepatide · 14 Aug 2025 · 3 likes Asking directly, because I could not find a straight answer: Does dual agonism explain the effect size, or is it dose? Session topic: SELECT ( N Engl J Med , 2023).…
-
Hypertension improvement and when medication needs revisiting Started this topic · Clinical › Comorbidities · 6 Aug 2025 · 41 likes Hypertension improvement and when medication needs revisiting Writing it up because I had to work it out twice and would rather nobody else did. Asking about a…
-
A request that was declined, and the reasoning — a second dataset Replied, post #12 · Documentation › Wiki requests · 6 Aug 2025 · 3 likes Suggesting content for a page: if you know a maintained page is missing something important, post a suggestion with specific content you think should be added.
-
What this community means by "a source", in practical terms Replied, post #59 · Start Here › Welcome · 5 Aug 2025 · 1 like Worth separating two things that post #55 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #63 · Evidence › Trials · 27 Jun 2025 · 2 likes On post #59 — agreed on the reasoning, with one qualification. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive…
-
Repeatability versus intermediate precision Replied, post #42 · Analytics › Method validation · 23 Jun 2025 · 0 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #23 · Practice › Reconstitution · 19 Jun 2025 · 0 likes Coming back to post #21, because the follow-up matters more than the original answer. A vial that will not fully dissolve: check in order: is the diluent genuinely room…
-
Coverage for the indication versus for the drug Replied, post #62 · Access › Insurance & coverage · 11 May 2025 · 0 likes Picking up post #59: that is the part I would want checked first. Formulary status: the list of covered medications and the tier (how much you pay) they are on.…
-
Titles that describe the question, not the situation Replied, post #9 · Start Here › How to Ask · 11 May 2025 · 11 likes I read post #7 twice before replying, because I had assumed the opposite. Context that matters: compound, how long in, current dose, relevant history. Context that does…
-
A report I filed that turned out to be wrong, and the correction Replied, post #26 · Sourcing › Vendor reports · 24 Apr 2025 · 18 likes post #25 is right about the mechanism and I think understates the practical bit. Blind submission is worth the effort: have someone else relabel the sample so neither…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #31 · Compounds › Cagrilintide & amylin analogues · 16 Apr 2025 · 7 likes The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The trade-off of a fixed combination is that you cannot titrate the…
-
Carryover and the ghost peak from last week's standard Replied, post #28 · Analytics › HPLC & UHPLC · 4 Apr 2025 · 1 like Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
-
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #13 · Evidence › Journal club · 28 Mar 2025 · 0 likes Coming back to post #11, because the follow-up matters more than the original answer. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #22 · Outcomes › Progress reports · 1 Mar 2025 · 4 likes Coming back to post #20, because the follow-up matters more than the original answer. Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #46 · Sourcing › Red flags · 31 Jan 2025 · 8 likes Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #81 · Analytics › COA interpretation · 29 Jan 2025 · 10 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #62 · Analytics › COA interpretation · 26 Jan 2025 · 19 likes Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is normal. The difference between a TFA salt and an acetate salt can be…
-
A claim built entirely on a subgroup analysis — what changed since Replied, post #2 · Evidence › Study critique · 23 Jan 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #23 · Compounds › Semaglutide · 11 Jan 2025 · 21 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Follow-up: Individual participant data versus aggregate data Replied, post #15 · Evidence › Meta-analyses · 8 Jan 2025 · 14 likes This follows post #12 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Fibre intake when total intake falls, and the constipation link Replied, post #12 · Nutrition & Training › Protein & intake · 31 Dec 2024 · 6 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
-
Oxidation pathways for methionine and tryptophan Replied, post #5 · Analytics › Impurities & related substances · 25 Dec 2024 · 8 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #46 · Sourcing › Regulatory · 4 Dec 2024 · 25 likes post #45 answers the question as asked. The question underneath it is different. Primary documents matter: regulatory positions are published in official documents.…
-
Why "any advice?" is the least effective ending for a post Replied, post #42 · Start Here › How to Ask · 16 Nov 2024 · 0 likes post #41 is right about the mechanism and I think understates the practical bit. Disagreeing with an answer you got: cite what you disagree with, say what contradicts…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #6 · Compounds › Semaglutide · 31 Oct 2024 · 21 likes On post #2 — agreed on the reasoning, with one qualification. The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4…
-
Why I ask for the gradient before I discuss the number Replied, post #29 · Analytics › HPLC & UHPLC · 20 Oct 2024 · 25 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #30 · Wellbeing › Mental health · 14 Oct 2024 · 31 likes Picking up post #27: that is the part I would want checked first. Body image and weight loss: large weight loss changes a person's relationship with their body in ways…
-
Telehealth prescribing models in the US Replied, post #8 · Regional › North America · 28 Sep 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Reporting a discrepancy without making an allegation Replied, post #19 · Sourcing › Vendor reports · 8 Aug 2024 · 20 likes On post #15 — agreed on the reasoning, with one qualification. Date the report: when the analysis was done matters. Material can degrade in storage. A report from two…
-
Journal club: FLOW and the renal composite, component by component Replied, post #68 · Evidence › Journal club · 15 Jul 2024 · 18 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…